Hepatic Intra-arterial Interferon Alpha 2b-based Immunotherapy Combined with 5-Fluorouracil (5-FU)-based Systemic Chemotherapy for Patients with Hepatocellular Carcinoma (HCC) not Responsive and/or not Eligible for Conventional Treatments: A Pilot Study

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.